Trump's surgeon general nominee reported $270,000 from supplement company, filings show

Dr Nicole Saphier, Donald Trump's nominee for US surgeon general, reported more than $200,000 in business income from a company she owns that sells dietary supplements, according to a financial disclosure and ethics agreement she filed last week, the Guardian reported.

The filing comes ahead of a Senate confirmation hearing scheduled for Wednesday. Saphier is a radiologist specializing in breast cancer at Memorial Sloan Kettering Cancer Center in New Jersey and was formerly a contributor to Fox News.

According to the Guardian, the dietary supplement industry is loosely regulated in the United States, and health and consumer advocates say the income raises concerns about Saphier's record. Some critics have gone further, likening certain supplement products to "snake oil," the report said.

The Guardian also reported that the disclosures pointed to tobacco-related investments, adding to questions raised by consumer and health advocates about potential conflicts of interest for a nominee who, if confirmed, would serve as the nation's leading voice on public health matters.

Details of the specific supplement company and the nature of Saphier's tobacco investments were not fully outlined in the available excerpt of the report. The Guardian indicated that further details on her financial holdings and the ethics agreement were expected to be examined as part of the confirmation process.

The surgeon general position requires Senate confirmation, and financial disclosures are a standard part of the vetting process for nominees to federal health leadership roles. Saphier's supporters and the White House have not yet publicly responded to the specific concerns raised in the report, according to the available excerpt.